genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2011
Anesthetics
Insights
GEN’s 30th Anniversary: Scotland
News
Studies Suggest eEF2 Kinase Represents a Target for Developing Fast Acting Antidepressants
Bioprocessing
APP Pharma to Plug $38M into Expanding NY Manufacturing Site
Insights
New Treatments for Sleep Apnea Sufferers
News
Piramal to Acquire Minrad in an Agreement Worth $40M
News
Teleflex Spends $2B on Arrow International
News
EpiCept Licenses Back Pain-Related Patent to Durect
News
Nycomed Will Pay Durect up to $202M in Posidur Development Agreement
News
Potential Blood Test for Mad Cow Disease Developed
1
2
3
Page 3 of 3
Scroll Up
Scroll Up
